Nanoparticle-based drug delivery system: the magic bullet for the treatment of chronic pulmonary diseases

S Pramanik, S Mohanto, R Manne… - Molecular …, 2021 - ACS Publications
Chronic pulmonary diseases encompass different persistent and lethal diseases, including
chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic …

[HTML][HTML] Traditional Chinese medicine combined with pulmonary drug delivery system and idiopathic pulmonary fibrosis: rationale and therapeutic potential

Y Zhang, P Lu, H Qin, Y Zhang, X Sun, X Song… - Biomedicine & …, 2021 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a progressive pulmonary interstitial inflammatory
disease of unknown etiology, and is also a sequela in severe patients with the Coronavirus …

Inhaled drug delivery: Past, present, and future

L Yue, X Zhang, C Zhao, R Chen, X Chen, L Rao - Nano Today, 2023 - Elsevier
Inhaled drug delivery has been an emerging route for the treatment of lung diseases with
clear advantages over oral and intravenous routes. However, the delivery efficacy is affected …

Antivirals and the potential benefits of orally inhaled drug administration in COVID-19 treatment

G Sahin, O Akbal-Dagistan, M Culha, A Erturk… - Journal of …, 2022 - Elsevier
Abstract Coronavirus Disease 2019 (COVID-19) pandemic has been on the agenda of
humanity for more than 2 years. In the meantime, the pandemic has caused economic …

Pulmonary drug delivery: an effective and convenient delivery route to combat COVID-19

S Alipour, L Mahmoudi, F Ahmadi - Drug delivery and translational …, 2023 - Springer
The recent outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China has spread
rapidly around the world, leading to a widespread and urgent effort to develop and use …

[HTML][HTML] Guidance on nebulization during the current COVID-19 pandemic

M Cazzola, J Ora, A Bianco, P Rogliani, MG Matera - Respiratory medicine, 2021 - Elsevier
Awareness of the risk of airborne transmission of SARS-CoV-2 makes patients hesitant
about using inhaled medications that are considered as a potential source of viral …

Dry powder inhalers in the digitalization era: current status and future perspectives

S Xiroudaki, A Schoubben, S Giovagnoli, DM Rekkas - Pharmaceutics, 2021 - mdpi.com
During the last decades, the term “drug delivery systems”(DDSs) has almost fully replaced
previously used terms, such as “dosage forms”, in an attempt to emphasize the importance …

The current and future role of technology in respiratory care

P Honkoop, O Usmani, M Bonini - Pulmonary Therapy, 2022 - Springer
Over the past few decades, technology and improvements in artificial intelligence have
dramatically changed major sectors of our day-to-day lives, including the field of healthcare …

Boosting lung accumulation of gallium with inhalable nano-embedded microparticles for the treatment of bacterial pneumonia

G Costabile, E Mitidieri, D Visaggio… - International Journal of …, 2022 - Elsevier
The potential of intra-venous gallium nitrate (GaN) administration against Pseudomonas
aeruginosa pneumonia was recently demonstrated in mice and in cystic fibrosis (CF) …

Understanding the performance of pressurized metered dose inhalers formulated with low Global warming potential propellants

H Wang, J Leal, M Ordoubadi, Z Minootan… - Aerosol Science and …, 2024 - Taylor & Francis
Switching to low-global warming potential (GWP) propellants for pressurized metered dose
inhalers (pMDIs) is crucial in current inhalation product development, as it is crucial to …